Journal profile · Biochemical Research Methods
Assay and Drug Development Technologies
ISSN 1540-658X · eISSN 1557-8127 · Mary Ann Liebert Inc. · UNITED STATES · Bimonthly · Founded 2002
Assay and Drug Development Technologies: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.87; subscription journal; review over 12 weeks (community reports); community-reported acceptance: fairly easy; 40 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Assay and Drug Development Technologies is published by Mary Ann Liebert Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Computational Drug Discovery Methods, Ion channel regulation and function and Receptor Mechanisms and Signaling, together about 23.9% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application. ASSAY and Drug Development Technologies coverage includes: -Assay design, target development, and high-throughput technologies- Hit to Lead optimization and medicinal chemistry through preclinical candidate selection- Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis- Approaches to assays configured for gene families, inherited, and infectious diseases- Assays and strategies for adapting model organisms to drug discovery- The use of stem cells as models of disease- Translation of phenotypic outputs to target identification- Exploration and mechanistic studies of the technical basis for assay and screening artifacts
Source: LetPub
Research area (LetPub): Biochemical Research Methods
Main research topics OpenAlex counts of recent articles; shares are approximate
- Computational Drug Discovery MethodsComputer Science10.6%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology6.9%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology6.4%
- Cell Image Analysis TechniquesBiochemistry, Genetics and Molecular Biology5.7%
- Monoclonal and Polyclonal Antibodies ResearchMedicine5.1%
- Cardiac electrophysiology and arrhythmiasMedicine4.9%
- 3D Printing in Biomedical ResearchEngineering4.6%
- Click Chemistry and ApplicationsChemistry4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemical Research Methods | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemical Research Methods | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemical Research Methods | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.87LetPub ·
- CiteScore 2026-06
- 3.8LetPub ·
- SJR 2026-06
- 0.33LetPub ·
- SNIP 2026-06
- 0.63LetPub ·
- h-index
- 52LetPub ·
- h-index
- 73OpenAlex ·
- i10-index
- 599OpenAlex ·
- 2-year mean citedness
- 2.58OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 2%LetPub ·
Volume
- Articles per year
- 38LetPub ·
Articles by year OpenAlex count · 1,471 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 26 | 2 | 8 |
| 2025 | 40 | 1 | 101 |
| 2024 | 33 | 5 | 146 |
| 2023 | 41 | 4 | 214 |
| 2022 | 38 | 5 | 286 |
| 2021 | 55 | 3 | 340 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Mary Ann Liebert Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2002
- ISSN
- 1540-658X
- Electronic ISSN
- 1557-8127
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Assay and Drug Development Technologies
What CAS zone is Assay and Drug Development Technologies in?
In the 2025 upgraded edition of the CAS Journal Ranking, Assay and Drug Development Technologies is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemical Research Methods / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Assay and Drug Development Technologies?
The latest impact factor listed by LetPub is 1.87; CiteScore 3.8, h-index 73.
How long does peer review take at Assay and Drug Development Technologies?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Assay and Drug Development Technologies?
According to LetPub and DOAJ records, Assay and Drug Development Technologies is indexed in SCIE and Scopus.
Is Assay and Drug Development Technologies open access, and what is the APC?
Assay and Drug Development Technologies is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .